Psychiatr Serv 52:967-969, July 2001
© 2001 American Psychiatric Association
A Program for Treating Olanzapine-Related Weight Gain
M. Patricia Ball, R.N., C.M.S.,
Vanessa B. Coons, B.A. and
Robert W. Buchanan, M.D.
This study evaluated the effectiveness of a Weight Watchers program for patients with schizophrenia who had olanzapine-related weight gain and ascertained whether the severity of patients' psychiatric symptoms was correlated with the patients' success in losing weight. Seven men and four women who had been treated with olanzapine and who had gained at least 7 percent of their pretreatment body weight attended Weight Watchers meetings and were offered supervised exercise sessions. The patients' weight, body mass index, and psychiatric symptoms were assessed and were compared with those of a matched comparison group who did not attend the Weight Watchers program. Only the men experienced significant weight loss. No correlation was found between weight loss and exercise or change in psychiatric symptoms.
This article has been cited by other articles:
|
|
|
|
 
M. Alvarez-Jimenez, S. E. Hetrick, C. Gonzalez-Blanch, J. F. Gleeson, and P. D. McGorry
Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials
The British Journal of Psychiatry,
August 1, 2008;
193(2):
101 - 107.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.S. Leslie, C.R. Hankey, and M.E.J. Lean
Weight gain as an adverse effect of some commonly prescribed drugs: a systematic review
QJM,
July 1, 2007;
100(7):
395 - 404.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Noel
ASHP Therapeutic Position Statement on the Use of Second-Generation Antipsychotic Medications in the Treatment of Adults with Psychotic Disorders
Am. J. Health Syst. Pharm.,
April 15, 2007;
64(8):
863 - 876.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Archie, J. O. Goldberg, N. Akhtar-Danesh, J. Landeen, L. McColl, and J. McNiven
Psychotic Disorders, Eating Habits, and Physical Activity: Who Is Ready for Lifestyle Changes?
Psychiatr Serv,
February 1, 2007;
58(2):
233 - 239.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. G. Robinson, M. G. Woerner, B. Napolitano, R. C. Patel, S. M. Sevy, H. Gunduz-Bruce, J. M. Soto-Perello, A. Mendelowitz, A. Khadivi, R. Miller, et al.
Randomized Comparison of Olanzapine Versus Risperidone for the Treatment of First-Episode Schizophrenia: 4-Month Outcomes
Am J Psychiatry,
December 1, 2006;
163(12):
2096 - 2102.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. S. McIntyre and J. Z. Konarski
Obesity and Psychiatric Disorders: Frequently Encountered Clinical Questions
Focus,
October 1, 2005;
3(4):
511 - 519.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. G Robinson, M. G Woerner, H. M Delman, and J. M Kane
Pharmacological Treatments for First-Episode Schizophrenia
Schizophr Bull,
July 1, 2005;
31(3):
705 - 722.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E K. Hester and M. R Thrower
Current Options in the Management of Olanzapine-Associated Weight Gain
Ann. Pharmacother.,
February 1, 2005;
39(2):
302 - 310.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Marder, S. M. Essock, A. L. Miller, R. W. Buchanan, D. E. Casey, J. M. Davis, J. M. Kane, J. A. Lieberman, N. R. Schooler, N. Covell, et al.
Physical Health Monitoring of Patients With Schizophrenia
Am J Psychiatry,
August 1, 2004;
161(8):
1334 - 1349.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. I. Ohlsen, J. Treasure, and L. S. Pilowsky
A dedicated nurse-led service for antipsychotic-induced weight gain: An evaluation
Psychiatr. Bull.,
May 1, 2004;
28(5):
164 - 166.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Treating Obesity: New Directions
Journal Watch Psychiatry,
May 22, 2003;
2003(522):
2 - 2.
[Full Text]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2001
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
